Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.11

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been given an average rating of “Buy” by the ten ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $19.11.

ASPN has been the subject of several recent research reports. Barclays cut their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Craig Hallum cut their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Finally, B. Riley cut their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $7.38 on Tuesday. The company has a 50 day moving average price of $10.22 and a 200-day moving average price of $16.06. Aspen Aerogels has a 52 week low of $6.70 and a 52 week high of $33.15. The firm has a market capitalization of $605.92 million, a PE ratio of 46.15 and a beta of 2.28. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities research analysts expect that Aspen Aerogels will post 0.17 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently modified their holdings of the stock. Sandia Investment Management LP purchased a new position in shares of Aspen Aerogels in the fourth quarter worth $89,000. AlphaQuest LLC raised its stake in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after purchasing an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in Aspen Aerogels during the fourth quarter valued at $164,000. Connors Investor Services Inc. purchased a new stake in Aspen Aerogels during the fourth quarter valued at $168,000. Finally, Journey Strategic Wealth LLC purchased a new stake in Aspen Aerogels during the fourth quarter valued at $178,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.